# 23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV

> **NIH NIH R13** · JOHNS HOPKINS UNIVERSITY · 2021 · $43,000

## Abstract

With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes
of death and disability in people living with HIV around the globe, including low and middle income
countries (LMIC). Large meetings, such as the Conference for Retroviruses and Opportunistic
Infections and the International AIDS Society Conference, are important venues for scientific
exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate
formats,that emphasize discussion and networking are critical to the career development of HIV
Comorbidity investigators. The International Workshop for Comorbidities and Adverse Drug
Reactions in HIV, now in its 23rd year, provides <200 delegates with an opportunity to come
together to discuss the latest findings and controversies in HIV Comorbidity research in one-room,
two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV
researchers with expertise in a specific comorbidity. Abstract presentations including 24 15-
minute talks and a poster session provide ample opportunity for researchers to present and get
feedback on their latest work. With this R13, we propose to enhance the 23rd Workshop (October
25th/26th in London) with the following aims: 1) to provide a forum for the latest HIV Comorbidity
research in LMIC by offering travel scholarships to LMIC investigators, supporting an
internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker,
and liaising with international training programs, 2) to support early-stage investigators with a
scholarship program and a Career Development Studio, and guided poster tour, 3) to increase
the impact of the Workshop through the webcast of plenary and abstract presentations. By
providing a “scientific home” to an increasing number of HIV Comorbidity investigators from
around the world, we hope to catalyze future research efforts in HIV Comorbidities and facilitate
the translation of research findings into clinical strategies that can improve the lifespan and
healthspan of PLWH.

## Key facts

- **NIH application ID:** 10327072
- **Project number:** 1R13AI165238-01
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** TODD T BROWN
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $43,000
- **Award type:** 1
- **Project period:** 2021-07-20 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10327072

## Citation

> US National Institutes of Health, RePORTER application 10327072, 23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV (1R13AI165238-01). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10327072. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*